Significant progress in preclinical pipeline targeting KRAS-driven solid tumor cancers with systemic administration demonstrating robust anti-tumor and anti-metastasis activity in orthotopic mouse ...

Discover Iovance's Q4'24 revenue growth, Proleukin's impact on Amtagvi's future, and how it faces competition like Obsidian's ...

A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a breakthrough in understanding the spread of oral squamous cell carcinoma ...

AbTree Biologics AG has signed an exclusive co-development and commercialization partnership with Shilpa Biologicals Pvt Ltd. (a fully owned subsidiary of Shilpa Medicare Limited) for its novel ...

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality worldwide. Current treatment modalities are few or ...

The novel therapy is anticipated to function like PD-1/PD-L1 blockade with significant clinical efficacy results in ...

Karnataka: Shilpa Biologicals Pvt Ltd., a fully owned subsidiary of Shilpa Medicare Limited has signed an exclusive ...

Professor Yuxiong Su, Professor Gao Zhang and Professor Jingya Pu. A collaborative research team from The University of Hong ...

We’ve gotten a lot better at fighting cancer, but there’s still a way to go. An important realization was that it’s not the ...